{
  "quoteSummary": {
    "result": [
      {
        "defaultKeyStatistics": {
          "maxAge": 1,
          "priceHint": {
            "raw": 2,
            "fmt": "2",
            "longFmt": "2"
          },
          "enterpriseValue": {
            "raw": 7570941440,
            "fmt": "7.57B",
            "longFmt": "7,570,941,440"
          },
          "forwardPE": {},
          "profitMargins": {
            "raw": 0.03366,
            "fmt": "3.37%"
          },
          "floatShares": {
            "raw": 96831402,
            "fmt": "96.83M",
            "longFmt": "96,831,402"
          },
          "sharesOutstanding": {
            "raw": 224260992,
            "fmt": "224.26M",
            "longFmt": "224,260,992"
          },
          "sharesShort": {},
          "sharesShortPriorMonth": {},
          "heldPercentInsiders": {},
          "heldPercentInstitutions": {},
          "shortRatio": {},
          "shortPercentOfFloat": {},
          "beta": {
            "raw": -0.399007,
            "fmt": "-0.4"
          },
          "morningStarOverallRating": {},
          "morningStarRiskRating": {},
          "category": null,
          "bookValue": {
            "raw": 44.889,
            "fmt": "44.89"
          },
          "priceToBook": {
            "raw": 0.55470157,
            "fmt": "0.55"
          },
          "annualReportExpenseRatio": {},
          "ytdReturn": {},
          "beta3Year": {},
          "totalAssets": {},
          "yield": {},
          "fundFamily": null,
          "fundInceptionDate": {},
          "legalType": null,
          "threeYearAverageReturn": {},
          "fiveYearAverageReturn": {},
          "priceToSalesTrailing12Months": {},
          "lastFiscalYearEnd": {
            "raw": 1490918400,
            "fmt": "2017-03-31"
          },
          "nextFiscalYearEnd": {
            "raw": 1553990400,
            "fmt": "2019-03-31"
          },
          "mostRecentQuarter": {
            "raw": 1112227200,
            "fmt": "2005-03-31"
          },
          "earningsQuarterlyGrowth": {},
          "revenueQuarterlyGrowth": {},
          "netIncomeToCommon": {
            "raw": 553379968,
            "fmt": "553.38M",
            "longFmt": "553,379,968"
          },
          "trailingEps": {
            "raw": 2.468,
            "fmt": "2.47"
          },
          "forwardEps": {},
          "pegRatio": {},
          "lastSplitFactor": "10/1",
          "lastSplitDate": {
            "raw": 1226448000,
            "fmt": "2008-11-12"
          },
          "enterpriseToRevenue": {
            "raw": 0.461,
            "fmt": "0.46"
          },
          "enterpriseToEbitda": {
            "raw": 3.369,
            "fmt": "3.37"
          },
          "52WeekChange": {
            "raw": "Infinity",
            "fmt": "\u00e2\u02c6\u017e%"
          },
          "SandP52WeekChange": {
            "raw": 0.12668931,
            "fmt": "12.67%"
          },
          "lastDividendValue": {},
          "lastCapGain": {},
          "annualHoldingsTurnover": {}
        },
        "earnings": {
          "maxAge": 86400,
          "earningsChart": {
            "quarterly": []
          },
          "financialsChart": {
            "yearly": [
              {
                "date": 2014,
                "revenue": {
                  "raw": 16383120000,
                  "fmt": "16.38B",
                  "longFmt": "16,383,120,000"
                },
                "earnings": {
                  "raw": 620860000,
                  "fmt": "620.86M",
                  "longFmt": "620,860,000"
                }
              },
              {
                "date": 2015,
                "revenue": {
                  "raw": 16436420000,
                  "fmt": "16.44B",
                  "longFmt": "16,436,420,000"
                },
                "earnings": {
                  "raw": 662640000,
                  "fmt": "662.64M",
                  "longFmt": "662,640,000"
                }
              },
              {
                "date": 2016,
                "revenue": {
                  "raw": 16757470000,
                  "fmt": "16.76B",
                  "longFmt": "16,757,470,000"
                },
                "earnings": {
                  "raw": 542400000,
                  "fmt": "542.4M",
                  "longFmt": "542,400,000"
                }
              },
              {
                "date": 2017,
                "revenue": {
                  "raw": 16439930000,
                  "fmt": "16.44B",
                  "longFmt": "16,439,930,000"
                },
                "earnings": {
                  "raw": 553380000,
                  "fmt": "553.38M",
                  "longFmt": "553,380,000"
                }
              }
            ],
            "quarterly": [
              {
                "date": "1Q2005",
                "revenue": {
                  "raw": 699437436,
                  "fmt": "699.44M",
                  "longFmt": "699,437,436"
                },
                "earnings": {
                  "raw": 96563551,
                  "fmt": "96.56M",
                  "longFmt": "96,563,551"
                }
              }
            ]
          },
          "financialCurrency": "INR"
        },
        "summaryProfile": {
          "address1": "SCO 38-39",
          "address2": "Sector 9d",
          "city": "Chandigarh",
          "zip": "160009",
          "country": "India",
          "phone": "91 17 2304 7777",
          "fax": "91 17 2304 7755",
          "website": "http://www.neclife.com",
          "industry": "Drug Manufacturers - Major",
          "sector": "Healthcare",
          "longBusinessSummary": "Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and Chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectables. In addition, it provides generic and OTC products for various therapeutic areas; a range of diagnostics products; empty hard gelatin capsules; and menthol and allied products, including menthol crystals, menthol flakes, peppermint oil, cis 3 hexenol, mentha piperita, Indian spearmint oil, menthones, mint blends, dementholised peppermint oil, and other customized mint based products. The company was incorporated in 1995 and is headquartered in Chandigarh, India.",
          "companyOfficers": [],
          "maxAge": 86400
        },
        "financialData": {
          "maxAge": 86400,
          "currentPrice": {
            "raw": 24.9,
            "fmt": "24.90"
          },
          "targetHighPrice": {
            "raw": 42.0,
            "fmt": "42.00"
          },
          "targetLowPrice": {
            "raw": 42.0,
            "fmt": "42.00"
          },
          "targetMeanPrice": {
            "raw": 42.0,
            "fmt": "42.00"
          },
          "targetMedianPrice": {
            "raw": 42.0,
            "fmt": "42.00"
          },
          "recommendationMean": {
            "raw": 2.0,
            "fmt": "2.00"
          },
          "recommendationKey": "buy",
          "numberOfAnalystOpinions": {
            "raw": 1,
            "fmt": "1",
            "longFmt": "1"
          },
          "totalCash": {
            "raw": 115702232,
            "fmt": "115.7M",
            "longFmt": "115,702,232"
          },
          "totalCashPerShare": {
            "raw": 0.516,
            "fmt": "0.52"
          },
          "ebitda": {
            "raw": 2247010048,
            "fmt": "2.25B",
            "longFmt": "2,247,010,048"
          },
          "totalDebt": {
            "raw": 970027456,
            "fmt": "970.03M",
            "longFmt": "970,027,456"
          },
          "quickRatio": {
            "raw": 0.441,
            "fmt": "0.44"
          },
          "currentRatio": {
            "raw": 1.172,
            "fmt": "1.17"
          },
          "totalRevenue": {
            "raw": 16439929856,
            "fmt": "16.44B",
            "longFmt": "16,439,929,856"
          },
          "debtToEquity": {
            "raw": 132.308,
            "fmt": "132.31"
          },
          "revenuePerShare": {
            "raw": 73.307,
            "fmt": "73.31"
          },
          "returnOnAssets": {
            "raw": 0.03953,
            "fmt": "3.95%"
          },
          "returnOnEquity": {
            "raw": 0.05644,
            "fmt": "5.64%"
          },
          "grossProfits": {
            "raw": 4896850000,
            "fmt": "4.9B",
            "longFmt": "4,896,850,000"
          },
          "freeCashflow": {
            "raw": 347676256,
            "fmt": "347.68M",
            "longFmt": "347,676,256"
          },
          "operatingCashflow": {
            "raw": 1987559936,
            "fmt": "1.99B",
            "longFmt": "1,987,559,936"
          },
          "earningsGrowth": {},
          "revenueGrowth": {},
          "grossMargins": {
            "raw": 0.29786,
            "fmt": "29.79%"
          },
          "ebitdaMargins": {
            "raw": 0.13668,
            "fmt": "13.67%"
          },
          "operatingMargins": {
            "raw": 0.098809995,
            "fmt": "9.88%"
          },
          "profitMargins": {
            "raw": 0.03366,
            "fmt": "3.37%"
          },
          "financialCurrency": "INR"
        }
      }
    ],
    "error": null
  }
}